Ryuta Kishii

Statistics

Publications

Citations

888

H-Index

Active since

2001

Affiliations

Merck & Co., Inc., Rahway, NJ, USA (United States)(Current)

United States Military Academy

WuXi AppTec (China)

Kyorin University

Ryuta Kishii is an author at Merck & Co., Inc., Rahway, NJ, USA (United States) specializing in drug discovery, antibacterial pharmacology, and pharmacology.

Publications per year

2001–2017

Publications

Structures of Kibdelomycin Bound to Staphylococcus aureus GyrB and ParE Showed a Novel U-Shaped Binding Mode

Jun Lu, Sangita B. Patel, Nandini Sharma et al. · ACS Chemical Biology · 2014 · 147 citations

Life Sciences, Medicinal Chemistry, Microbiology +13

Target Preference of 15 Quinolones againstStaphylococcus aureus, Based on Antibacterial Activities and Target Inhibition

Masaya Takei, Hideyuki Fukuda, Ryuta Kishii et al. · Antimicrobial Agents and Chemotherapy · 2001 · 121 citations · Full text

Life Sciences, Infectious Diseases, Microbiology +13

Oxabicyclooctane-Linked Novel Bacterial Topoisomerase Inhibitors as Broad Spectrum Antibacterial Agents

Sheo B. Singh, David E. Kaelin, Jin Wu et al. · ACS Medicinal Chemistry Letters · 2014 · 76 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +17

Contributions of the 8-Methoxy Group of Gatifloxacin to Resistance Selectivity, Target Preference, and Antibacterial Activity against Streptococcus pneumoniae

Hideyuki Fukuda, Ryuta Kishii, Masaya Takei et al. · Antimicrobial Agents and Chemotherapy · 2001 · 76 citations · Full text

Life Sciences, Infectious Diseases, Microbiology +14

Relationship between the expression of ompF and quinolone resistance in Escherichia coli

Ryuta Kishii, Masaya Takei · Journal of Infection and Chemotherapy · 2009 · 63 citations

Life Sciences, Infectious Diseases, Microbiology +14

1–5 of 19